Therapeutic anti-inflammatory effects of luteolin on endotoxin-induced uveitis in Lewis rats

Journal of Veterinary Medical Science

Volumn 78, Issue 8, 2016, Pages 1381-1384

  Kanai, Kazutaka ^a   Nagata, Sho ^a   Hatta, Takuya ^a   Sugiura, Yuichi ^a   Sato, Kazuaki ^a   Yamashita, Yohei ^a   Kimura, Yuya ^a   Itoh, Naoyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Anti inflammatory effect; Endotoxin induced uveitis; Luteolin; Prednisolone; Therapeutic effect

Indexed keywords

ANTIINFLAMMATORY AGENT; ENDOTOXIN; LUTEOLIN; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR;

ANIMAL; AQUEOUS HUMOR; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; INFLAMMATION; LEWIS RAT; MALE; RAT; TREATMENT OUTCOME; UVEITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AQUEOUS HUMOR; DINOPROSTONE; DISEASE MODELS, ANIMAL; ENDOTOXINS; INFLAMMATION; LUTEOLIN; MALE; NITRIC OXIDE; RATS; RATS, INBRED LEW; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 84985916595     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.16-0196     Document Type: Article

References (29)

1. Attoub, S., Hassan, A. H., Vanhoecke, B., Iratni, R., Takahashi, T., Gaben, A. M., Bracke, M., Awad, S., John, A., Kamalboor, H. A., Al Sultan, M. A., Arafat, K., Gespach, C. and Petroianu, G. 2011. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur. J. Pharmacol. 651: 18–25.
2. Behar-Cohen, F. F., Savoldelli, M., Parel, J. M., Goureau, O., Thillaye-Goldenberg, B., Courtois, Y., Pouliquen, Y. and de Kozak, Y. 1998. Reduction of corneal edema in endotoxin-induced uveitis after application of L-NAME as nitric oxide synthase inhibitor in rats by iontophoresis. Invest. Ophthalmol. Vis. Sci. 39: 897–904.
3. Bellot, J. L., Palmero, M., García-Cabanes, C., Espí, R., Hariton, C. and Orts, A. 1996. Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit. Inflamm. Res. 45: 203–208.
4. Carnahan, M. C. and Goldstein, D. A. 2000. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr. Opin. Ophthalmol. 11: 478–483.
5. Chen, C. Y., Peng, W. H., Tsai, K. D. and Hsu, S. L. 2007. Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci. 81: 1602–1614.
6. Chen, F. T., Liu, Y. C., Yang, C. M. and Yang, C. H. 2012. Anti-inflammatory effect of the proteasome inhibitor bortezomib on endotoxin-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 53: 3682–3694.
7. Dai, L. M., Cheng, H., Li, W. P., Liu, S. Q., Chen, M. Z. and Xu, S. Y. 1985. The influence of luteolin on experimental inflammatory models in rats. Acta Anhui. Med. Univ. 20: 1–3.
8. Impellizzeri, D., Esposito, E., Di Paola, R., Ahmad, A., Campolo, M., Peli, A., Morittu, V. M., Britti, D. and Cuzzocrea, S. 2013. Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. Arthritis Res. Ther. 15: R192.
9. Jia, Z., Nallasamy, P., Liu, D., Shah, H., Li, J. Z., Chitrakar, R., Si, H., McCormick, J., Zhu, H., Zhen, W. and Li, Y. 2015. Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway. J. Nutr. Biochem. 26: 293–302.
10. Kanai, K., Hatta, T., Nagata, S., Sugiura, Y., Sato, K., Yamashita, Y., Kimura, Y. and Itoh, N. 2016. Luteolin attenuates endotoxin-induced uveitis in Lewis rats. J. Vet. Med. Sci. 78: 1229–1335.
11. Kanai, K., Ito, Y., Nagai, N., Itoh, N., Hori, Y., Chikazawa, S., Hoshi, F. and Higuchi, S. 2012. Effects of instillation of eye-drops containing disulfiram and hydroxypropyl-β-cyclodextrin inclusion complex on endotoxin-induced uveitis in rats. Curr. Eye Res. 37: 124–131.
12. Li, L. P., Wu, X. D., Chen, Z. J., Sun, S. Y., Ye, J. F., Zeng, S. and Jiang, H. D. 2013. Interspecies difference of luteolin and apigenin after oral administration of Chrysanthemum morifolium extract and prediction of human pharmacokinetics. Pharmazie 68: 195–200.
13. Murphy, C. C., Ayliffe, W. H., Booth, A., Makanjuola, D., Andrews, P. A. and Jayne, D. 2004. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 111: 352–356.
14. Nabavi, S. F., Braidy, N., Gortzi, O., Sobarzo-Sanchez, E., Daglia, M., Skalicka-Woźniak, K. and Nabavi, S. M. 2015. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review. Brain Res. Bull. 119 Pt A: 1–11.
15. Nathan, C. and Xie, Q. W. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915–918.
16. Osman, N. H., Said, U. Z., El-Waseef, A. M. and Ahmed, E. S. 2015. Luteolin supplementation adjacent to aspirin treatment reduced dimethylhydrazine-induced experimental colon carcinogenesis in rats. Tumour Biol. 36: 1179–1190.
17. Pandurangan, A. K. and Esa, N. M. 2014. Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review. Asian Pac. J. Cancer Prev. 15: 5501–5508.
18. Richelle, M., Pridmore-Merten, S., Bodenstab, S., Enslen, M. and Offord, E. A. 2002. Hydrolysis of isoflavone glycosides to aglycones by β-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J. Nutr. 132: 2587–2592.
19. Rosenbaum, J. T., McDevitt, H. O., Guss, R. B. and Egbert, P. R. 1980. Endotoxin-induced uveitis in rats as a model for human disease. Nature 286: 611–613.
20. Rosenbaum, J. T. 1989. Uveitis. An internist’s view. Arch. Intern. Med. 149: 1173–1176.
21. Sande, P. H., Dorfman, D., Fernandez, D. C., Chianelli, M., Domínguez Rubio, A. P., Franchi, A. M., Silberman, D. M., Rosenstein, R. E. and Sáenz, D. A. 2014. Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation. Br. J. Pharmacol. 171: 5696–5707.
22. Seelinger, G., Merfort, I. and Schempp, C. M. 2008. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med. 74: 1667–1677.
23. Toguri, J. T., Lehmann, C., Laprairie, R. B., Szczesniak, A. M., Zhou, J., Denovan-Wright, E. M. and Kelly, M. E. 2014. Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis. Br. J. Pharmacol. 171: 1448–1461.
24. Tracey, K. J. and Cerami, A. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45: 491–503.
25. Yadav, U. C., Srivastava, S. K. and Ramana, K. V. 2007. Aldose reductase inhibition prevents endotoxin-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 48: 4634–4642.
26. Yadav, U. C., Subramanyam, S. and Ramana, K. V. 2009. Prevention of endotoxin-induced uveitis in rats by benfotiamine, a lipophilic analogue of vitamin B1. Invest. Ophthalmol. Vis. Sci. 50: 2276–2282.
27. Yang, P., de Vos, A. F. and Kijlstra, A. 1996. Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide. Invest. Ophthalmol. Vis. Sci. 37: 77–85.
28. Zhang, X. Y., Hayasaka, S., Hayasaka, Y., Cui, H. S. and Chi, Z. L. 2007. Effect of N-acetylcysteine on lipopolysaccharide-induced uveitis in rats. Jpn. J. Ophthalmol. 51: 14–20.
29. Zheng, C., Lei, C., Chen, Z., Zheng, S., Yang, H., Qiu, Y. and Lei, B. 2015. Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis. Mol. Vis. 21: 403–411.